Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07625605 · ClinicalTrials.gov registry record · NA
The Meals Study for Amyotrophic Lateral Sclerosis and Parkinson's Disease
A NA study, sponsored by The University of Tennessee, Knoxville.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
NCT07625605 is a NA study that has completed, run by The University of Tennessee, Knoxville. The registered enrollment target is 43 participants.
The verdict
NCT07625605, a NA study, has completed, sponsored by The University of Tennessee, Knoxville.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
Study Summary
Brief summary template The goal of this trial is to test the feasibility and efficacy of the Mediterranean-DASH Intervention for Neurodegenerative Delay (the MIND diet) in people living with amyotrophic lateral sclerosis (ALS) and Parkinson's disease (PD) and healthy controls. The main question\[s\] it aims to answer are: * How feasibile is our educational dietary intervention, which teaches participants with ALS, PD, and healthy controls to eat by the neuroprotective MIND dietary pattern? * How does the MIND dietary pattern affect the gut microbiome, metabolome, and lipidome in people with a neurodegenerative disease (ALS or PD) and healthy controls? * Does the MIND diet affect clinical measures of ALS and PD? * Does the MIND diet affect human biomarkers of systemic inflammation, metabolism, and neurodegeneration? Participants will: * Receive a MIND diet cookbook, a folder with educational handouts, and weekly emails with links to educational videos about the MIND diet. * Complete a food diary, a MIND diet tracker, and a weekly questionnaire about their experience of eating by the MIND diet. * Collect stool specimens at the beginning, middle, and end of the study. * Undergo venipuncture at the beginning and end of the study.
Interventions
- BEHAVIORAL The MIND diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2023-11-20 |
| Est. Completion | 2025-05-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07625605
The ClinicalTrials.gov registry entry for NCT07625605 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Tennessee, Knoxville, which has 81 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which The MIND diet is the first listed.
NCT07625605 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07625605 about?
NCT07625605 is a clinical study titled "The Meals Study for Amyotrophic Lateral Sclerosis and Parkinson's Disease". Brief summary template The goal of this trial is to test the feasibility and efficacy of the Mediterranean-DASH Intervention for Neurodegenerative Delay (the MIND diet) in people living with amyotrophic lateral sclerosis (ALS) and Parkinson's disease (PD) and healthy controls. The main question\[s\...
What is the current status of trial NCT07625605?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2023-11-20. Estimated completion is 2025-05-21.
What interventions are being tested in trial NCT07625605?
The interventions under investigation include: The MIND diet (BEHAVIORAL).
Who is sponsoring clinical trial NCT07625605?
This trial is sponsored by The University of Tennessee, Knoxville, which has 81 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.